The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury

American Journal of Nephrology

Volumn 32, Issue 6, 2010, Pages 522-532

  Li, Min ^a   Khan, Altaf M ^a   Maderdrut, Jerome L ^a   Simon, Eric E ^a,b   Batuman, Vecihi ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Innate immunity; Pituitary adenylate cyclase activating polypeptide; Proximal tubule cells; Toll like receptors

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; HISTOLOGY; IN VITRO STUDY; INNATE IMMUNITY; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WILD TYPE;

ACUTE KIDNEY INJURY; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANOXIA; APOPTOSIS; CHEMOKINE CCL2; CUMULUS CELLS; EPITHELIAL CELLS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERLEUKIN-6; KIDNEY TUBULES, PROXIMAL; MICE; MYELOID DIFFERENTIATION FACTOR 88; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4;

EID: 77958498968     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321491     Document Type: Article

References (40)

1. Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109:e102-e107.
2. Jang HR, Rabb H: The innate immune response in ischemic acute kidney injury. Clin Immunol 2009; 130: 41-50.
3. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der Poll T, Florquin S, Leemans JC: Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/ reperfusion injury. PLoS One 2008; 3:e3596.
4. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB: TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 2007; 178: 6252-6258.
5. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van 't Veer C: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 2002; 168: 1286-1293.
6. Han J: MyD88 beyond Toll. Nat Immunol 2006; 7: 370-371.
7. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859.
8. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renalassociated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894-2903.
9. Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB: TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 2008; 19: 923-932.
10. Zager RA, Johnson AC, Lund S, Randolph-Habecker J: Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol 2007; 292:F304-F312.
11. Chowdhury P, Sacks SH, Sheerin NS: Tolllike receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol 2006; 145: 346-356.
12. Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Kramer BK, Colvin RB, Heeger PS, Murphy BT, Schroppel B: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
13. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ: Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 2004; 172: 2629-2635.
14. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, Han J, Beutler B: Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4: 1223-1229.
15. Beutler B: Innate immunity: an overview. Mol Immunol 2004; 40: 845-859.
16. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
17. Li M, Balamuthusamy S, Khan AM, Maderdrut JL, Simon EE, Batuman V: Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury. Peptides 2010; 31: 592-602.
18. Li M, Balamuthusamy S, Khan AM, Maderdrut JL, Simon EE, Batuman V: Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure. J Mol Neurosci 2010, E-pub ahead of print.
19. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T: Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 2001; 167: 3463-3469.
20. Terryn S, Jouret F, Vandenabeele F, Smolders I, Moreels M, Devuyst O, Steels P, Van Kerkhove E: A primary culture of mouse proximal tubular cells, established on collagencoated membranes. Am J Physiol Renal Physiol 2007; 293:F476-F485.
21. Meldrum KK, Meldrum DR, Hile KL, Burnett AL, Harken AH: A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res 2001; 99: 288-293.
22. Koedel U, Merbt UM, Schmidt C, Angele B, Popp B, Wagner H, Pfister HW, Kirschning CJ: Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am J Pathol 2007; 171: 200-213.
23. Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS: Differential induction of the Toll-like receptor 4-MyD88-dependent and-independent signaling pathways by endotoxins. Infect Immun 2005; 73: 2940-2950.
24. Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, Eriksson K, Hagberg H, Mallard C: Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009; 183: 7471-7477.
25. Dear JW, Yasuda H, Hu X, Hieny S, Yuen PS, Hewitt SM, Sher A, Star RA: Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: Acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int 2006; 69: 832-836.
26. Lafrance JP, Miller DR: Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 2010; 21: 345-352.
27. Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009; 2009: 137072.
28. Nogueira E, Ponciano VC, Naka EL, Marques GD, Cenedeze MA, Camara NO, Pacheco-Silva A: Toll-like receptors-related genes in kidney transplant patients with chronic allograft nephropathy and acute rejection. Int Immunopharmacol 2009; 9: 673-676.
29. Armant MA, Fenton MJ: Toll-like receptors: A family of pattern-recognition receptors in mammals. Genome Biol 2002; 3:REVIEWS3011.
30. Anders HJ, Banas B, Schlondorff D: Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15: 854-867.
31. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J: The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 2010; 6: 224-235.
32. Goldstein DR, Tesar BM, Akira S, Lakkis FG: Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571-1578.
33. O'Neill LA: The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem Soc Trans 2003; 31: 643-647.
34. Gao Y, Fang X, Tong Y, Liu Y, Zhang B: TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother 2009; 63: 442-450.
35. Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J: TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 2009; 4:e5674.
36. Takeda K, Akira S: TLR signaling pathways. Semin Immunol 2004; 16: 3-9.
37. Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB: Mechanisms of the TRIF-induced interferon-stimulated response element and NFkappaB activation and apoptosis pathways. J Biol Chem 2004; 279: 15652-15661.
38. Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C, Roos M, Kirschning C, Heemann U, Lutz J: Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 2010; 25: 853-860.
39. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK: Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008; 23: 842-852.
40. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK: Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006; 21: 1231-1239.